ID: 132089180 | Neanderthal introgressed variant-containing enhancer experimental_81997 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (148114511..148114680) | | |
ID: 126807544 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr5:147609822-147611021 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (148230259..148231458) | | |
ID: 124901185 | uncharacterized LOC124901185 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (148083931..148093924, complement) | | |
ID: 123575587 | Sharpr-MPRA regulatory region 6578 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (148145986..148146280) | | |
ID: 108178993 | CAGE-defined high expression enhancer downstream of SPINK6 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (148223983..148224556) | | |
ID: 105378220 | MARCO like [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (148238525..148243580) | | |
ID: 100874442 | high mobility group nucleosome binding domain 1 pseudogene 16 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (148221360..148221642, complement) | | |
ID: 408187 | serine peptidase inhibitor Kazal type 14 (putative) [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (148168546..148175619) | SPINK5L2 | |
ID: 404203 | serine peptidase inhibitor Kazal type 6 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (148202778..148215137) | BUSI2, UNQ844 | 615868 |
ID: 11005 | serine peptidase inhibitor Kazal type 5 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (148063980..148137382) | LEKTI, LETKI, NETS, NS, VAKTI | 605010 |